BG Medicine Announces Availability of Galectin-3 Testing Through Cleveland HeartLab LLC

WALTHAM, Mass., Oct. 27, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel, biomarker-based diagnostics, announced today that Cleveland HeartLab, Inc. is now offering BGM Galectin-3TM testing services.
MORE ON THIS TOPIC